Syndax Pharmaceuticals Inc.SNDX

Close of Friday, October 23, 2026 · Syndax Pharmaceuticals Inc. is trading below its Pivot, OnlyAlpha's long-term trend line.

Price

$13.40

vs its Pivot

-34.4%

OnlyAlpha Score

Trend

Below its Pivot

Last 12 months. Solid line: price. Dashed green: the Pivot.

Returns

1 month	Year to date	1 year	3 years / yr	5 years / yr
-25.4%	-36.2%	-11.3%	—	—

No dividend in the last 12 months.

Who runs and owns it

In these funds

IBB · 0.11%IWM · 0.05%

Big investors that own it (latest 13F)

OrbiMed

0.6% of holdings

Suppliers, customers and partners

SNDX sells to

Incyte

axatilimab

From the companies' own annual reports filed with the SEC.

Healthcare · Biotech

ACET -49%ALNY -23%ARGX +2%ARWR -19%ASND +3%AXSM -28%BBIO -6%BCAX -20%BIIB +26%BMRN -4%BNTX -10%CORT +17%

Get SNDX in your free daily emailAfter every close: whether SNDX is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track SNDX free → Full Stock check